Results: 1-5 |
Results: 5

Authors: KAWASAKI K HAYASHI Y WANG Y SUZUKI S MORITA Y NAKAMURA T NARITA K DOE W ITOH H KURODA Y
Citation: K. Kawasaki et al., EXPRESSION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN GASTRIC-CANCER, Journal of gastroenterology and hepatology, 13(9), 1998, pp. 936-944

Authors: FERGUSON A CAMPIERI M DOE W PERSSON T NYGARD G
Citation: A. Ferguson et al., ORAL BUDESONIDE AS MAINTENANCE THERAPY IN CROHNS-DISEASE - RESULTS OFA 12-MONTH STUDY, Alimentary pharmacology & therapeutics, 12(2), 1998, pp. 175-183

Authors: CAMPIERI M FERGUSON A DOE W PERSSON T NILSSON LG MALCHOW H PRANTERA C MANI V OMORAIN C SELBY W PALLONE F DIPIETRALATA MM SJODAHL R FLORIN T SMITH P BIANCHI P LOFBERG R RUTGEERTS P SMALLWOOD R LAMERS HW TASMANJONES C HUNTER JO HODGSON H DANIELSSON A LEE FI PIACITELLI G GIOVANNI S ELLIS A WEIR DG
Citation: M. Campieri et al., ORAL BUDESONIDE IS AS EFFECTIVE AS ORAL PREDNISOLONE IN ACTIVE CROHNS-DISEASE, Gut, 41(2), 1997, pp. 209-214

Authors: LENGYEL E WANG H STEPP E JUAREZ J WANG Y DOE W PFARR CM BOYD D
Citation: E. Lengyel et al., REQUIREMENT OF AN UPSTREAM AP-1 MOTIF FOR THE CONSTITUTIVE AND PHORBOL ESTER-INDUCIBLE EXPRESSION OF THE UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR GENE, The Journal of biological chemistry, 271(38), 1996, pp. 23176-23184

Authors: CAMPIERI M FERGUSON A DOE W
Citation: M. Campieri et al., ORAL BUDESONIDE COMPETES FAVORABLY WITH PREDNISOLONE IN ACTIVE CROHNS-DISEASE, Gastroenterology, 108(4), 1995, pp. 790-790
Risultati: 1-5 |